Cell Research Contents: Volume 32 Number 4

In this Issue: Research Highlight Article Letter to the Editor Correction

Cell Research Contents: Volume 32 Issue 4

Research Highlight

Vein to artery: the first arteriogenesis in the mammalian embryo Siyeon Rhee & Joseph C. Wu Research Highlight | 14 February 2022 Cell Research 32 | doi:10.1038/s41422-022-00629-7

Revealing the secret behind Smo cholesterylation Yuhong Han & Jin Jiang Research Highlight | 02 March 2022 Cell Research 32 | doi:10.1038/s41422-022-00636-8

Transcriptomic profiling fuels the derivation of stable pig epiblast stem cells Cuiqing Zhong, Ronghui Li & Juan Carlos Izpisua Belmonte Research Highlight | 12 January 2022 Cell Research 32 | doi:10.1038/s41422-021-00609-3

Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine Hua Peng & Yang-Xin Fu Research Highlight | 08 March 2022 Cell Research 32 | doi:10.1038/s41422-022-00634-w

Article

Heterogeneity in endothelial cells and widespread venous arterialization during early vascular development in mammals Siyuan Hou, Zongcheng Li, Ji Dong, Yun Gao, Zhilin Chang et al. Article | 25 January 2022 Cell Research 32 | doi:10.1038/s41422-022-00615-z

Cryo-EM structure of the nuclear ring from Xenopus laevis nuclear pore complex Gaoxingyu Huang, Xiechao Zhan, Chao Zeng, Xuechen Zhu, Ke Liang et al. Article | 17 February 2022 Cell Research 32 | doi:10.1038/s41422-021-00610-w

EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription Xiaoqing Lu, Liwei An, Guangjian Fan, Lijuan Zang, Weiyi Huang et al. Article | 23 February 2022 Cell Research 32 | doi:10.1038/s41422-022-00628-8

Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters Yong-Qiang Deng, Na-Na Zhang, Yi-Fei Zhang, Xia Zhong, Sue Xu et al. Article | 24 February 2022 Cell Research 32 | doi:10.1038/s41422-022-00630-0

Generation and characterization of stable pig pregastrulation epiblast stem cell lines Minglei Zhi, Jinying Zhang, Qianzi Tang, Dawei Yu, Shuai Gao et al. Article | 30 November 2021 Cell Research 32 | doi:10.1038/s41422-021-00592-9

Letter to the Editor

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant Na-Na Zhang, Rong-Rong Zhang, Yi-Fei Zhang, Kai Ji, Xiao-Chuan Xiong et al. Letter to the Editor | 14 February 2022 Cell Research 32 | doi:10.1038/s41422-022-00626-w

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant Shuai Xia, Jasper Fuk-Woo Chan, Lijue Wang, Fanke Jiao, Kenn Ka-Heng Chik et al. Letter to the Editor | 27 January 2022 Cell Research 32 | doi:10.1038/s41422-022-00617-x

Spontaneous necroptosis and autoinflammation are blocked by an inhibitory phosphorylation on MLKL during neonatal development Xinxin Zhu, Na Yang, Yu Yang, Feiyang Yuan, Dandan Yu et al. Letter to the Editor | 02 November 2021 Cell Research 32 | doi:10.1038/s41422-021-00583-w

Structural basis for the gating modulation of Kv4.3 by auxiliary subunits Demin Ma, Cheng Zhao, Xiaochen Wang, Xiaoxiao Li, Yi Zha et al. Letter to the Editor | 07 January 2022 Cell Research 32 | doi:10.1038/s41422-021-00608-4

Correction

Author Correction: Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma Yongping Cui, Hongyan Chen, Ruibin Xi, Heyang Cui, Yahui Zhao et al. Correction | 17 February 2022 Cell Research 32 | doi:10.1038/s41422-022-00625-x

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Cell Research.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.